ASCO COVID-19 Telehealth Updates, May 8, 2020
Click HERE to view the slide presentation from the webinar.

CMS Finalizes FY 2021 Inpatient Rule
On September 2, the Centers for Medicare and Medicaid Services (CMS) issued the FY 2021 Inpatient Prospective Payment System (IPPS) Final Rule. ASH submitted comments in July on the proposed rule. The Society is pleased that many of the provisions ASH supported have been finalized, including the creation of a new Medicare Severity Diagnosis Related Group (MS-DRG) for Chimeric Antigen Receptor (CAR) T-cell Immunotherapy, now the highest weighted MS-DRG with an unadjusted national base payment of around $240,000. CMS also finalized its proposal to exclude clinical trial cases from the calculation of the weight of the new MS-DRG in order to account for the cost differentiation between clinical trial and non-clinical trial cases. CMS’s final ruling on CAR-T reimbursement is a major advocacy win for ASH!

ASH Diversity, Equity, and Inclusion Efforts